Pharmaceutical company Roche is to sponsor a multi-country trial to evaluate the efficacy of molecularly guided therapy versus chemotherapy in CUP patients.  The intention is to run the trial in approximately 25 (mostly European) countries. Last week it was agreed, within Roche, that there would be UK participation. There is more information on our Blog.

< Back to articles